Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -43.41% is in line with its 1-year average of -39.91%, near the low end of its 1-year range (-43.41%–-36.40%).
As of the fiscal period ended Wednesday, December 31, 2025. 8.78% below its 12-month average of -39.91%.
Limited history available
BLSM Return on Invested Capital (ROIC) has fewer than three reported periods, so a trend chart would be misleading.
RETURN ON INVESTED CAPITAL (ROIC)
-43.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-39.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-8.78%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.29%
median of 484 covered companies
CURRENT VS SECTOR MEDIAN
-53.45%
vs the sector median at left
BlossomHill Therapeutics, Inc.
Market Cap
$579.88M
Return on Invested Capital (ROIC)
-43.41%
TTM Avg
-39.91%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$573.38M
Return on Invested Capital (ROIC)
-45.62%
TTM Avg
-46.61%
3Y Avg
-61.97%
5Y Avg
-71.18%
Market Cap
$587.93M
Return on Invested Capital (ROIC)
-4.97%
TTM Avg
-6.49%
3Y Avg
-6.53%
5Y Avg
-6.86%
Market Cap
$569.56M
Return on Invested Capital (ROIC)
27.87%
TTM Avg
-1.63%
3Y Avg
-31.88%
5Y Avg
-39.02%
Market Cap
$596.36M
Return on Invested Capital (ROIC)
-56.99%
TTM Avg
-66.45%
3Y Avg
-57.50%
5Y Avg
-60.06%
Market Cap
$561.67M
Return on Invested Capital (ROIC)
-25.42%
TTM Avg
25.46%
3Y Avg
-12.61%
5Y Avg
-20.42%
Market Cap
$600.84M
Return on Invested Capital (ROIC)
58.60%
TTM Avg
17.42%
3Y Avg
-47.16%
5Y Avg
-23.48%
Market Cap
$551.09M
Return on Invested Capital (ROIC)
-18.20%
TTM Avg
-95.31%
3Y Avg
-87.63%
5Y Avg
-71.60%
Market Cap
$547.86M
Return on Invested Capital (ROIC)
-0.81%
TTM Avg
-8.59%
3Y Avg
-110.96%
5Y Avg
-102.03%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BlossomHill Therapeutics, Inc. (BLSM) | $579.88M | -43.41% | -39.91% | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | -45.62% | -46.61% | -61.97% | -71.18% |
| OrthoPediatrics Corp. (KIDS)vs › | $587.93M | -4.97% | -6.49% | -6.53% | -6.86% |
| CorMedix Inc. (CRMD)vs › | $569.56M | 27.87% | -1.63% | -31.88% | -39.02% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | -56.99% | -66.45% | -57.50% | -60.06% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.67M | -25.42% | 25.46% | -12.61% | -20.42% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.84M | 58.60% | 17.42% | -47.16% | -23.48% |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | -18.20% | -95.31% | -87.63% | -71.60% |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | -0.81% | -8.59% | -110.96% | -102.03% |
| Climb Bio, Inc. (CLYM)vs › | $632.76M | -26.94% | -40.40% | -38.31% | -45.27% |
ROIC
-43.4%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -43.41% |
| 2024-12-31 | -36.40% |
